3 September 2010
Cell Publishes on the Critical Role of Metals in Alzheimer's Disease 24 August 2010
Prana secures key PBT2 patents in the United States and Europe 3 August 2010
Prana Biotechnology is cited in New Scientist Magazine article entitled 'Alzheimer's Unlocked: New Keys to a Cure' 19 July 2010
Prana's research presented at ICAD 14 July 2010 1 July 2010
New PBT2 Data in 2010 Hot Topics Session at ICAD 28 June 2010
Investment by Quintiles, Placement of 225 Million Shares 21 June 2010
Comprehensive review of the role of metals in Alzheimer's Disease 1 June 2010
Prana Biotechnology to Present Findings at the American Aging Association's 39th Annual Meeting in June 2010 29 April 2010
Prana provides analysis of PBT2 therapeutic strategy for AD 20 April 2010
Prana to commence Phase llb trial on PBT2 19 April 2010
New Analysi of Prana's Clinical Trial is Published in the Journal of Alzheimer's Disease 14 January 2010
Appointment of Independent Director 12 November 2009
Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent Expert 9 September 2009
Prana Secures Additional $6 Million Financing 2 September 2009
Prana to Present at Rodman and Renshaw Global Investment Conference 12 August 2009
Prana Allowed Key Patent for PBT2 in the United States 5 August 2009
Prana is Granted Key Patent by European Patent Office 16 July 2009
Prana's Head of Research Presents New Efficacy Data in Hot Topics Session at ICAD 10 July 2009
Prana to Provide Update on PBT2 Efficacy Data 2 April 2009
Study Corroborates Prana's AD Strategy 11 March 2009
Prana's PBT2 Prevents Synaptic Loss in Alzheimer's Disease 5 January 2009
Dr Rudolph Tanzi to Present at the 2009 Goldman Sachs Healthcare CEOc Unscripted: A View from the Top Conference 28 November 2008
Prana Provides Update on Research and Development Programs at AGM 18 November 2008
Prana 's Compound Featured in Annals of Neurology 30 October 2008
Prana to Present at Rodman and Renshaw 10th Annual Healthcare Conference 30 July 2008
The Lancet Neurology Publishes Clinical Results of PBT2 23 July 2008
Prana Announces Conference Call Following ICAD Presentations 17 July 2008
Prana Selected for Hot Topics at ICAD 10 July 2008
Neuron to Publish PBT2 Pre Clinical Research 8 July 2008
Co-Founding Scientist Addressed US Senate Special Committee on Aging 21 May 2008
Prana Announces $7million Placement to Fund Research Programs 13 May 2008
PNAS Publication Describes New Class of Anti-Amyloid Drugs 6 May 2008
Novel Drug Candidates Discovered for Parkinson's Disease Use 18 March 2008
Prana Reports Increase in Percent of Major Shareholder 14 March 2008
Prana Announces Updated Investor Presentation 14 March 2008
Prana to be Featured in Alzheimer's Disease Conference Call 4 March 2008
Prana responds to Press Comments on Visits by Pharmaceutical Experts 26 February 2008
Prana Announces Success in Phase IIa Clinical Trial of PBT2 18 January 2008
Prana today announced that the current online addition of Neurobiology of Aging Journal, has published a paper entitled, Zinc and Copper Modulate Alzheimer A-beta Levels in Human Cerebrospinal Fluid 2 January 2008
Prana Announces Completion of Phase IIa Trial of PBT2 in Alzheimer's Disease Patients Media Release Archive
2007 Media Releases
2006 Media Releases
2005 Media Releases
2004 Media Releases
2003 Media Releases
2002 Media Releases
2001 Media Releases
2000 Media Releases
|
